Thea Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for THEA PHARMA, and what generic alternatives to THEA PHARMA drugs are available?
THEA PHARMA has seven approved drugs.
There are four US patents protecting THEA PHARMA drugs.
There are ninety-four patent family members on THEA PHARMA drugs in thirty-four countries and twenty-one supplementary protection certificates in ten countries.
Summary for Thea Pharma
| International Patents: | 94 |
| US Patents: | 4 |
| Tradenames: | 7 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Thea Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thea Pharma | BETIMOL | timolol | SOLUTION/DROPS;OPHTHALMIC | 020439-002 | Mar 31, 1995 | AT | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Thea Pharma | COSOPT | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 020869-001 | Apr 7, 1998 | AT1 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| Thea Pharma | AKTEN | lidocaine hydrochloride | GEL;OPHTHALMIC | 022221-001 | Oct 7, 2008 | RX | Yes | Yes | 8,759,401 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Thea Pharma | IYUZEH | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 216472-001 | Dec 13, 2022 | RX | Yes | Yes | 8,637,054 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Thea Pharma | ZIOPTAN | tafluprost | SOLUTION/DROPS;OPHTHALMIC | 202514-001 | Feb 10, 2012 | AT | RX | Yes | Yes | 9,999,593 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Thea Pharma | BETIMOL | timolol | SOLUTION/DROPS;OPHTHALMIC | 020439-001 | Mar 31, 1995 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Thea Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Thea Pharma | COSOPT | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 020869-001 | Apr 7, 1998 | 4,797,413*PED | ⤷ Subscribe |
| Thea Pharma | AZASITE | azithromycin | SOLUTION/DROPS;OPHTHALMIC | 050810-001 | Apr 27, 2007 | 6,861,411 | ⤷ Subscribe |
| Thea Pharma | COSOPT | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 020869-001 | Apr 7, 1998 | 4,619,939*PED | ⤷ Subscribe |
| Thea Pharma | AZASITE | azithromycin | SOLUTION/DROPS;OPHTHALMIC | 050810-001 | Apr 27, 2007 | 5,192,535 | ⤷ Subscribe |
| Thea Pharma | BETIMOL | timolol | SOLUTION/DROPS;OPHTHALMIC | 020439-001 | Mar 31, 1995 | 5,231,095 | ⤷ Subscribe |
| Thea Pharma | COSOPT | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 020869-001 | Apr 7, 1998 | 6,248,735 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for THEA PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 2%/0.5% | ➤ Subscribe | 2005-10-11 |
| ➤ Subscribe | Ophthalmic Solution | 1% | ➤ Subscribe | 2011-03-03 |
| ➤ Subscribe | Ophthalmic Solution | 0.0015% | ➤ Subscribe | 2016-02-10 |
International Patents for Thea Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Morocco | 34324 | ⤷ Subscribe |
| Cyprus | 1120351 | ⤷ Subscribe |
| China | 102958509 | ⤷ Subscribe |
| Taiwan | 201000104 | ⤷ Subscribe |
| South Korea | 20190067272 | ⤷ Subscribe |
| South Korea | 101988642 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Thea Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3461484 | 301101 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
| 0509752 | 49/1999 | Austria | ⤷ Subscribe | PRODUCT NAME: DORZOLAMID ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE DORZOLAMIDHYDROCHLORID, UND TIMOLOL ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE TIMOLOLMALEAT; NAT. REGISTRATION NO/DATE: 1-22701, 1-22702 19980828; FIRST REGISTRATION: DK 9794 19980306 |
| 0364417 | 9690031-1 | Sweden | ⤷ Subscribe | PRODUCT NAME: LATANOPROST |
| 3461484 | SPC/GB21/033 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: A COMBINATION OF LATANOPROST AND NETARSUDIL; REGISTERED: UK EU/1/20/1502(FOR NI) 20210107; UK PLGB 16053/0034 20210107 |
| 0509752 | 2000C/001 | Belgium | ⤷ Subscribe | PRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306 |
| 3461484 | 122021000036 | Germany | ⤷ Subscribe | PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
